Economic information and modeling reportBudget impact model
Results
5 evidence topics · 5 sources
First-line recurrent or metastatic HPV-negative head and neck squamous cell carcinoma, in combination with pembrolizumab
Economic information and modeling reportBudget impact model
5 evidence topics · 5 sources